1.
Service Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1.
Markets Covered
1.2.2.
Years Considered for
Study
1.2.3.
Key Market
Segmentations
2.
Research Methodology
2.1.
Objective of the Study
2.2.
Baseline Methodology
2.3.
Key Industry Partners
2.4.
Major Association and Secondary Sources
2.5.
Forecasting Methodology
2.6.
Data Triangulation & Validation
2.7.
Assumptions and Limitations
3.
Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4.
Voice of Customer
5. Global Clinical Trials Market Outlook
5.1.
Market Size &
Forecast
5.1.1.
By Value
5.2.
Market Share &
Forecast
5.2.1. By Type (Pharmaceutical
Trials, Medical Device Trials)
5.2.2. By Phase (Phase I,
Phase II, Phase III, Phase IV)
5.2.3. By Study Design
(Interventional, Observational, Expanded Access)
5.2.4. By Indication
(Autoimmune/Inflammation, Oncology, CNS, Diabetes, Cardiovascular, Others)
5.2.5. By End User
(Clinical Research Organizations, Pharmaceutical and Biotechnological
Companies, Clinical Testing Laboratories, Others)
5.2.6. By Region
5.2.7.
By Company (2023)
5.3.
Market Map
5.3.1.
By Type
5.3.2.
By Phase
5.3.3.
By Study Design
5.3.4.
By Indication
5.3.5.
By End User
5.3.6.
By Region
6. Asia Pacific Clinical Trials Market Outlook
6.1.
Market Size &
Forecast
6.1.1.
By Value
6.2.
Market Share &
Forecast
6.2.1.
By Type
6.2.2.
By Phase
6.2.3.
By Study Design
6.2.4.
By Indication
6.2.5.
By End User
6.2.6.
By Country
6.3.
Asia Pacific:
Country Analysis
6.3.1.
China Clinical
Trials Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Type
6.3.1.2.2.
By Phase
6.3.1.2.3.
By Study Design
6.3.1.2.4.
By Indication
6.3.1.2.5.
By End User
6.3.2.
India Clinical
Trials Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Type
6.3.2.2.2.
By Phase
6.3.2.2.3.
By Study Design
6.3.2.2.4.
By Indication
6.3.2.2.5.
By End User
6.3.3.
Australia Clinical
Trials Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Type
6.3.3.2.2.
By Phase
6.3.3.2.3.
By Study Design
6.3.3.2.4.
By Indication
6.3.3.2.5.
By End User
6.3.4.
Japan Clinical
Trials Market Outlook
6.3.4.1.
Market Size & Forecast
6.3.4.1.1.
By Value
6.3.4.2.
Market Share & Forecast
6.3.4.2.1.
By Type
6.3.4.2.2.
By Phase
6.3.4.2.3.
By Study Design
6.3.4.2.4.
By Indication
6.3.4.2.5.
By End User
6.3.5.
South Korea Clinical
Trials Market Outlook
6.3.5.1.
Market Size & Forecast
6.3.5.1.1.
By Value
6.3.5.2.
Market Share & Forecast
6.3.5.2.1.
By Type
6.3.5.2.2.
By Phase
6.3.5.2.3.
By Study Design
6.3.5.2.4.
By Indication
6.3.5.2.5.
By End User
7. Europe Clinical Trials Market Outlook
7.1.
Market Size &
Forecast
7.1.1.
By Value
7.2.
Market Share &
Forecast
7.2.1.
By Type
7.2.2.
By Phase
7.2.3.
By Study Design
7.2.4.
By Indication
7.2.5.
By End User
7.2.6.
By Country
7.3.
Europe: Country
Analysis
7.3.1.
France Clinical
Trials Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Type
7.3.1.2.2.
By Phase
7.3.1.2.3.
By Study Design
7.3.1.2.4.
By Indication
7.3.1.2.5.
By End User
7.3.2.
Germany Clinical
Trials Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Type
7.3.2.2.2.
By Phase
7.3.2.2.3.
By Study Design
7.3.2.2.4.
By Indication
7.3.2.2.5.
By End User
7.3.3.
Spain Clinical
Trials Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Type
7.3.3.2.2.
By Phase
7.3.3.2.3.
By Study Design
7.3.3.2.4.
By Indication
7.3.3.2.5.
By End User
7.3.4.
Italy Clinical
Trials Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Type
7.3.4.2.2.
By Phase
7.3.4.2.3.
By Study Design
7.3.4.2.4.
By Indication
7.3.4.2.5.
By End User
7.3.5.
United Kingdom
Clinical Trials Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Type
7.3.5.2.2.
By Phase
7.3.5.2.3.
By Study Design
7.3.5.2.4.
By Indication
7.3.5.2.5.
By End User
8. North America Clinical Trials Market Outlook
8.1.
Market Size &
Forecast
8.1.1.
By Value
8.2.
Market Share &
Forecast
8.2.1.
By Type
8.2.2.
By Phase
8.2.3.
By Study Design
8.2.4.
By Indication
8.2.5.
By End User
8.2.6.
By Country
8.3.
North America:
Country Analysis
8.3.1.
United States
Clinical Trials Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Type
8.3.1.2.2.
By Phase
8.3.1.2.3.
By Study Design
8.3.1.2.4.
By Indication
8.3.1.2.5.
By End User
8.3.2.
Mexico Clinical
Trials Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Type
8.3.2.2.2.
By Phase
8.3.2.2.3.
By Study Design
8.3.2.2.4.
By Indication
8.3.2.2.5.
By End User
8.3.3.
Canada Clinical
Trials Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Type
8.3.3.2.2.
By Phase
8.3.3.2.3.
By Study Design
8.3.3.2.4.
By Indication
8.3.3.2.5.
By End User
9. South America Clinical Trials Market Outlook
9.1.
Market Size &
Forecast
9.1.1.
By Value
9.2.
Market Share &
Forecast
9.2.1. By Type
9.2.2. By Phase
9.2.3. By Study Design
9.2.4. By Indication
9.2.5. By End User
9.2.6. By Country
9.3.
South America:
Country Analysis
9.3.1.
Brazil Clinical
Trials Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Type
9.3.1.2.2.
By Phase
9.3.1.2.3.
By Study Design
9.3.1.2.4.
By Indication
9.3.1.2.5.
By End User
9.3.2.
Argentina Clinical
Trials Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Type
9.3.2.2.2.
By Phase
9.3.2.2.3.
By Study Design
9.3.2.2.4.
By Indication
9.3.2.2.5.
By End User
9.3.3.
Colombia Clinical
Trials Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Type
9.3.3.2.2.
By Phase
9.3.3.2.3.
By Study Design
9.3.3.2.4.
By Indication
9.3.3.2.5.
By End User
10. Middle East and Africa Clinical Trials Market Outlook
10.1.
Market Size &
Forecast
10.1.1.
By Value
10.2.
Market Share &
Forecast
10.2.1.
By Type
10.2.2.
By Phase
10.2.3.
By Study Design
10.2.4.
By Indication
10.2.5.
By End User
10.2.6.
By Country
10.3.
MEA: Country
Analysis
10.3.1.
South Africa
Clinical Trials Market Outlook
10.3.1.1.
Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2.
Market Share & Forecast
10.3.1.2.1.
By Type
10.3.1.2.2.
By Phase
10.3.1.2.3.
By Study Design
10.3.1.2.4.
By Indication
10.3.1.2.5.
By End User
10.3.2.
Saudi Arabia
Clinical Trials Market Outlook
10.3.2.1.
Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2.
Market Share & Forecast
10.3.2.2.1.
By Type
10.3.2.2.2.
By Phase
10.3.2.2.3.
By Study Design
10.3.2.2.4.
By Indication
10.3.2.2.5.
By End User
10.3.3.
UAE Clinical Trials
Market Outlook
10.3.3.1.
Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2.
Market Share & Forecast
10.3.3.2.1.
By Type
10.3.3.2.2.
By Phase
10.3.3.2.3.
By Study Design
10.3.3.2.4.
By Indication
10.3.3.2.5.
By End User
10.3.4.
Egypt Clinical
Trials Market Outlook
10.3.4.1.
Market Size & Forecast
10.3.4.1.1.
By Value
10.3.4.2.
Market Share & Forecast
10.3.4.2.1.
By Type
10.3.4.2.2.
By Phase
10.3.4.2.3.
By Study Design
10.3.4.2.4.
By Indication
10.3.4.2.5.
By End User
11.
Market Dynamics
11.1.
Drivers
11.2.
Challenges
12.
Market Trends &
Developments
12.1.
Recent Developments
12.2.
Service Launches (If Any)
12.3.
Mergers &
Acquisitions (If Any)
13.
Global Clinical
Trials Market: SWOT Analysis
14. Porter’s Five Forces Analysis
14.1.
Competition in the
Industry
14.2.
Potential of New
Entrants
14.3.
Power of Suppliers
14.4.
Power of Customers
14.5.
Threat of Substitute Services
15.
Competitive
Landscape
15.1.
SGS SA
15.1.1.
Business Overview
15.1.2.
Company Snapshot
15.1.3.
Products &
Services
15.1.4.
Financials (In case
of listed)
15.1.5.
Recent Developments
15.1.6.
SWOT Analysis
15.2.
ACM Global Laboratories
15.3.
Medpace, Inc.
15.4.
ICON plc.
15.5.
Charles River Laboratories International, Inc.
15.6.
Parexel International (MA) Corporation
15.7.
F. Hoffmann-La Roche
Ltd
15.8.
ІQVІА, Іnс.
15.9.
Syneos Health Inc.
15.10.
Thermo Fisher Scientific, Inc.
16.
Strategic Recommendations
17. About Us & Disclaimer